Company Filing History:
Years Active: 2013
Title: Ela Kolb: Innovator in Spider Venom Research
Introduction
Ela Kolb is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biochemistry, particularly through her research on spider venom. Her innovative work has led to the development of new therapeutic approaches for pain management.
Latest Patents
Ela Kolb holds a patent for "Peptides isolated from spider venom, and uses thereof." This patent describes isolated spider venom peptides that serve as potent and selective ion channel blockers. The implications of her research are profound, as these peptides can be utilized in compositions and methods for treating pain.
Career Highlights
Ela Kolb is associated with Alomone Preclinical Ltd., a company that focuses on the development of innovative solutions in the field of neuroscience. Her work at Alomone has positioned her as a key player in the research community, contributing to advancements in pain treatment.
Collaborations
Ela has collaborated with notable colleagues, including Alon Meir and Ronit Simcha Cherki. These partnerships have enhanced her research efforts and broadened the impact of her work in the scientific community.
Conclusion
Ela Kolb's contributions to the field of spider venom research exemplify the potential of innovative science in addressing complex medical challenges. Her work continues to inspire advancements in pain management therapies.